Malignant News and Research

RSS

First trial to combine a biologic agent with a conventional chemotherapy agent for the treatment of ovarian cancer

Researchers found the addition of thalidomide to topotecan for the treatment of recurrent ovarian cancer significantly increases the response to therapy and the duration of progression free survival without additional toxicity.

28 Mar 2006

Call to speed access to innovative advances for all breast cancer patients

Breast cancer specialists and advocates at the 5th European Breast Cancer Conference (EBCC-5) called for patients to have equal and speedy access to new breast cancer treatments and procedures, as soon as they are validated by comparative clinical trials.

28 Mar 2006

RNAi-based inhibitors for created for nearly every human and mouse gene - available to all genetic researchers

An international public-private research team led by scientists at the Broad Institute of MIT and Harvard announced today the construction and availability of an extensive library of molecular reagents to silence most human and mouse genes.

28 Mar 2006

Determining the risk of ovarian malignancy in postmenopausal women with abnormal findings in the PLCO screening trial

Reporting on the largest study of its kind today at the Society of Gynecologic Oncologists 37th Annual Meeting on Women's Cancer, researchers presented new criteria for detecting ovarian cancer malignancy in postmenopausal asymptomatic women, 55 to 74 years old.

28 Mar 2006

Treatment of uterine (endometrial) cancer by laparoscopy gives better patient quality of life

Laparoscopy proves safe, reduces hospital stay, and results in improved quality of life.

27 Mar 2006

Innovative automatic system stops patients falling through gaps

Every day in hospitals around the country, thousands of patients undergo CT, MRI, X-ray and other kinds of scans, producing detailed images of their bodies. Specially trained doctors "read" those images to look for problems, and then send a report of what they've found to each patient's own doctor.

23 Mar 2006

Environmental chemicals implicated in cancer

New research at the University of Liverpool suggests that environmental contaminants, such as pesticides, are more influential in causing cancer than previously thought.

21 Mar 2006

Pesticides more influential in causing cancer than previously thought

New research at the University of Liverpool suggests that environmental contaminants, such as pesticides, are more influential in causing cancer than previously thought.

20 Mar 2006

Capsaicin drives prostate cancer cells to kill themselves

Capsaicin, the stuff that turns up the heat in jalapeqos, not only causes the tongue to burn, it also drives prostate cancer cells to kill themselves, according to studies published in the March 15 issue of Cancer Research.

15 Mar 2006

Thalidomide improves remission in myeloma

Myeloma is one of the least curable cancers and involves plasma cells, the white blood cells that produce antibodies.

9 Mar 2006

Lilly launches phase III trial of Enzastaurin

One of the deadliest and rarest forms of cancer is the focus of a Phase III study initiated by Eli Lilly and Company today.

9 Mar 2006

ATF2 protein may play a crucial role in cancer's ability to resist chemotherapy and radiation treatment

Researchers at Purdue University have discovered a molecular mechanism that may play a crucial role in cancer's ability to resist chemotherapy and radiation treatment and that also may be involved in Alzheimer's and heart disease.

9 Mar 2006

Photodynamic therapy lighting the way for medical treatments

For the millions of people who suffer from acne, sun damage or even worse, skin cancer, there is a light of hope - photodynamic therapy or PDT.

6 Mar 2006

Schering-Plough provides update on phase II study of Vicriviroc

Schering-Plough Corporation has provided an update on vicriviroc, its investigational CCR5 receptor antagonist, currently being evaluated by the NIH-sponsored Adult AIDS Clinical Trials Group (ACTG) in an ongoing Phase II clinical study of 118 U.S. treatment-experienced HIV patients.

6 Mar 2006

Attaching new cytokine to neural stem cells derived from bone marrow kills brain tumor cells

Attaching a recently discovered cytokine to neural stem cells derived from bone marrow, researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute have developed a tool to track and kill malignant brain tumor cells and provide long-term protection against their return.

1 Mar 2006

Scientists reprogramme malignant melanoma cells to become normal pigment cells

Scientists at Northwestern University and the Stowers Institute for Medical Research have reprogrammed malignant melanoma cells to become normal melanocytes, or pigment cells, a development that may hold promise in treating of one of the deadliest forms of cancer.

1 Mar 2006

Malignant News and Research

First trial to combine a biologic agent with a conventional chemotherapy agent for the treatment of ovarian cancer

Call to speed access to innovative advances for all breast cancer patients

RNAi-based inhibitors for created for nearly every human and mouse gene - available to all genetic researchers

Determining the risk of ovarian malignancy in postmenopausal women with abnormal findings in the PLCO screening trial

Treatment of uterine (endometrial) cancer by laparoscopy gives better patient quality of life

Innovative automatic system stops patients falling through gaps

Environmental chemicals implicated in cancer

Pesticides more influential in causing cancer than previously thought

Capsaicin drives prostate cancer cells to kill themselves

Thalidomide improves remission in myeloma

Lilly launches phase III trial of Enzastaurin

ATF2 protein may play a crucial role in cancer's ability to resist chemotherapy and radiation treatment

Photodynamic therapy lighting the way for medical treatments

Schering-Plough provides update on phase II study of Vicriviroc

Attaching new cytokine to neural stem cells derived from bone marrow kills brain tumor cells

Scientists reprogramme malignant melanoma cells to become normal pigment cells

Papillary lesions of the breast should be surgically excised to avoid missing a cancer

Link between rheumatoid arthritis and cancer examined

Combination therapy improves Acquired Immunodeficiency Syndrome-Related Lymphoma outcome

Study associates chronic, severe inflammation with increased lymphoma risk among RA patients

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News